<p>A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis</p>
Elizabeth Hoon(University of the West of England), Catherine Hill(Royal Adelaide Hospital), Rachel Black(The University of Sydney), Carlee Ruediger(Queen Elizabeth Hospital), Tiffany K. Gill(Aalborg University)
Cited by 18
Related Papers
Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
|The Lancet Rheumatology|2023|584
Prevalence, Deaths, and Disability‐Adjusted Life Years Due to Musculoskeletal Disorders for 195 Countries and Territories 1990–2017
|Arthritis & Rheumatology|2020|395
Global, regional, and national burden of other musculoskeletal disorders, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
|The Lancet Rheumatology|2023|370
Global, regional, and national burden of gout, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
|The Lancet Rheumatology|2024|210
Risk of mortality in patients with giant cell arteritis: A systematic review and meta-analysis
|Seminars in Arthritis and Rheumatism|2016|83